PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease (Q34896568)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease |
scientific article |
Statements
1 reference
PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease (English)
1 reference
Solbritt Rantapää-Dahlqvist
0 references
Göran Hallmans
1 reference
Martin Johansson
1 reference
Lisbeth Arlestig
1 reference
1 January 2006
1 reference
1 reference
Identifiers
1 reference